BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 17031387)

  • 1. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
    Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
    J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iron chelator Dp44mT does not protect myocytes against doxorubicin.
    Hasinoff BB; Patel D
    J Inorg Biochem; 2009 Jul; 103(7):1093-101. PubMed ID: 19535146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    Simůnek T; Sterba M; Popelová O; Kaiserová H; Adamcová M; Hroch M; Hasková P; Ponka P; Gersl V
    Br J Pharmacol; 2008 Sep; 155(1):138-48. PubMed ID: 18536744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
    Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
    Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable inhibitory effects on the formation of dinitrosyl iron complexes by deferoxamine and salicylaldehyde isonicotinoyl hydrazone in K562 cells.
    Meczynska S; Lewandowska H; Sochanowicz B; Sadlo J; Kruszewski M
    Hemoglobin; 2008; 32(1-2):157-63. PubMed ID: 18274993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New iron chelators in anthracycline-induced cardiotoxicity.
    Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
    Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
    Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
    Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
    Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
    PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
    Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
    Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro.
    Schröterová L; Kaiserová H; Baliharová V; Velík J; Gersl V; Kvasnicková E
    Physiol Res; 2004; 53(6):683-91. PubMed ID: 15588138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.